Sign in

CIK 0001796280

  • Non-accelerated filer

Oric Pharmaceuticals, Inc.

Sign in to watch
Ticker
ORIC
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
471787157
Phone
+1 650-388-5600
Business address
240 E. GRAND AVE., 2ND FLOOR, SOUTH SAN FRANCISCO, CA, 94080
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$1,519,090
in 5 filings, $1.5M under 10b5-1 plans

Net −$1,519,090. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2021-03-30 ORBIMED ADVISORS LLC Director Sale −27,869 $23.93 $667K 2,212,571
2021-03-29 ORBIMED ADVISORS LLC Director Sale −75,555 $23.31 $1.8M 2,240,440
2021-03-26 ORBIMED ADVISORS LLC Director Sale −27,816 $23.88 $664K 2,315,995
2021-03-25 ORBIMED ADVISORS LLC Director Sale −51,523 $24.70 $1.3M 2,343,811
2021-03-24 ORBIMED ADVISORS LLC Director Sale −32,959 $24.80 $817K 2,395,334
2021-03-23 ORBIMED ADVISORS LLC Director Sale −3,992 $24.32 $97K 2,428,293
2021-03-22 ORBIMED ADVISORS LLC Director Sale −7,673 $26.47 $203K 2,432,285
2021-03-19 ORBIMED ADVISORS LLC Director Sale −21,275 $26.47 $563K 2,439,958
2021-03-18 ORBIMED ADVISORS LLC Director Sale −6,059 $28.03 $170K 2,461,233
2021-03-17 ORBIMED ADVISORS LLC Director Sale −18,790 $28.43 $534K 2,467,292
2021-03-16 ORBIMED ADVISORS LLC Director Sale −41,353 $27.72 $1.1M 2,486,082
2021-03-15 ORBIMED ADVISORS LLC Director Sale −89,210 $29.14 $2.6M 2,527,435
2021-03-12 ORBIMED ADVISORS LLC Director Sale −90,521 $30.29 $2.7M 2,616,645
2021-03-11 ORBIMED ADVISORS LLC Director Sale −58,551 $33.04 $1.9M 2,707,166
2020-04-28 ORBIMED ADVISORS LLC Director Conversion +1,875,000 2,156,250
2020-04-28 ORBIMED ADVISORS LLC Director Conversion +373,356 2,529,606
2020-04-28 ORBIMED ADVISORS LLC Director Conversion +236,111 2,765,717
2020-04-28 ORBIMED ADVISORS LLC Director Conversion · Series B Preferred Stock −1,875,000 0
2020-04-28 ORBIMED ADVISORS LLC Director Conversion · Series C Preferred Stock −373,356 0
2020-04-28 ORBIMED ADVISORS LLC Director Conversion · Series D Preferred Stock −236,111 0

Page 1 of 2 · 21 trades